Skip to main content

David A. Spellman

Chief Accounting Officer

Akebia Therapeutics, Inc. (AKBA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About David A. Spellman

David A. Spellman is recorded as Chief Accounting Officer at Akebia Therapeutics, Inc. (AKBA). Akebia Therapeutics, Inc. reported in an 8-K filed June 13, 2023 that David A. Spellman resigned as Senior Vice President, Chief Financial Officer, Treasurer, principal financial officer and principal accounting officer, effective June 23, 2023. The proxy statement of Akebia Therapeutics, Inc. reports total compensation of $942,627 for David A. Spellman in fiscal 2023, including a base salary of $254,759. Disclosed compensation is on record for 3 fiscal years.

“On June 9, 2023, David A. Spellman, Senior Vice President, Chief Financial Officer, Treasurer, principal financial officer and principal accounting officer of Akebia Therapeutics, Inc. (the "Company"), notified the Company of his intent to resign.”
Akebia Therapeutics, Inc. Form 8-K, filed June 13, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Akebia Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Akebia Therapeutics, Inc. (AKBA) $254,759 $942,627
2022 Akebia Therapeutics, Inc. (AKBA) $504,666 $1,585,841
2021 Akebia Therapeutics, Inc. (AKBA) $473,871 $1,721,477

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.